Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma

Author： Yang Q-F.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.61, Iss.3, 2000-06, pp. : 211-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BAG-1 Expression Correlates with Bcl-2, p53, Differentiation, Estrogen and Progesterone Receptors in Invasive Breast Carcinoma

By Tang Shou-Ching  

Breast Cancer Research and Treatment, Vol. 84, Iss. 3, 2004-04 ,pp. : 203-213

Springer Publishing Company

Access to resources Recommend Favorite

Bax, Bcl-2, and p53 Expression in Endometrial Cancer

By Sakuragi N.   Salah-eldin A-e.   Watari H.   Itoh T.   Inoue S.   Moriuchi T.   Fujimoto S.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 288-296

Academic Press

Access to resources Recommend Favorite

p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma

By Olumi A.F.   Weidner N.   Presti J.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1264-1274

Spandidos Publications

Access to resources Recommend Favorite

Enhanced Apoptosis Correlates with Poor Survival in Patients with Laryngeal Cancer but not with Cell Proliferation, bcl-2 or p53 Expression

By Hirvikoski P.   Kumpulainen E.   Virtaniemi J.   Pirinen R.   Salmi L.   Halonen P.   Johansson R.   Kosma V.-M.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 231-237

Elsevier

Access to resources Recommend Favorite